Skip to main content
SpringerLink
Log in

Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome is increasingly required; however, existing methods of determining the required dose are cumbersome and not applicable in all centers. A previous study suggested that the required parenteral dose of histamine H2-receptor antagonists correlated with the previous oral dose. In the present study, in 31 patients with Zollinger-Ellison syndrome we evaluated the hypothesis that an effective parenteral histamine H2-receptor antagonist dose could be predicted from the previous oral dose. Twenty-three patients were taking oral ranitidine (mean 1.3 g/day), six patients famotidine (152 mg/day), and two patients cimetidine (1.8 g/day). Each patient was treated with a continuous intravenous infusion of the equivalent dose of ranitidine (mean dose 1 mg/kg/hr with 35% requiring 0.5 mg/kg/hr, 49% 1 mg/kg/hr, 3% 1.5 mg/kg/hr, 10% 2 mg/kg/hr, and 3% 2.5 mg/kg/hr. This dose of ranitidine acutely controlled acid secretion (<10 meq/hr) in all patients. To evaluate long-term efficacy and safety, 20 patients were maintained on this dose through the peri-and postoperative periods. Mean duration was 7.1 days with 25% treated 3–5 days, 40% 6–8 days, 30% 8–10 days, and 5%>10 days. The predicted dose continued to control acid secretion in 95% of patients with one patient requiring one dose adjustment. No biochemical, clinical, or hematological toxicity was seen, although ranitidine was stopped in one patient because of skin rash. These results demonstrate that the parenteral dose of ranitidine required to control acid secretion in patients with Zollinger-Ellison syndrome can be predicted from the oral dose. This predicted dose will be acutely effective in all patients in reducing acid secretion to <10 meq/hr, the established level of control, will remain effective in 95% of patients for up to 11 days, and is safe. By utilizing the oral dose to predict the intravenous dose, repeated dose titrations will be avoided and thus this method should be generally useful in all settings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wolfe MM, Jensen RT: Zollinger-Ellison syndrome. N Engl J Med 317:1200–1209, 1987

    Google Scholar 

  2. Anderson DK: Current diagnosis and management of Zollinger-Ellison syndrome. Ann Surg 210:685–703, 1989

    Google Scholar 

  3. Jensen RT, Maton PN: Zollinger-Ellison syndrome.In The Stomach. S Gustavsson, D Kumar, DY Graham (eds). London, Churchill-Livingston, 1991, pp 341–374

    Google Scholar 

  4. Norton JA, Doppman JL, Collen MJ, Harmon JW, Maton PN, Gardner JD, Jensen RT: Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome. Ann Surg 203:468–479, 1986

    Google Scholar 

  5. Norton JA, Jensen RT: Unresolved surgical issues in the management of Zollinger-Ellison syndrome. World J Surg 15:151–159, 1991

    Google Scholar 

  6. Wolfe MM, Alexander RW, McGuigan JE: Extrapancreatic extraintestinal gastrinoma; effective treatment by surgery. N Engl J Med 306:1533–1536, 1982

    Google Scholar 

  7. Norton JA, Doppman JL, Cornelius MJ, Maton PN, Gardner JD, Jensen RT: Effect of parathyroidectomy in patients with hyperparathyroidism and Zollinger-Ellison syndrome and multiple endocrine neoplasia-type I. Surgery 102:958–966, 1987

    Google Scholar 

  8. Jensen RT, Doppman JL, Gardner JD: Gastrinoma.In The Exocrine Pancreas: Biology, Pathobiology and Disease. E DiMagno, JD Gardner, E Lebenthal, G Scheele (eds). New York, Raven Press, 1986, pp 727–744

    Google Scholar 

  9. Malagelada JR, Edis AJ, Adson MA, van Heerden JA, Go VLW: Medical and surgical options in the management of patients with gastrinoma. Gastroenterology 84:1524–1532, 1983

    Google Scholar 

  10. Stabile BE, Passero E Jr: Benign and malignant gastrinoma. Am J Surg 149:144–148, 1985

    Google Scholar 

  11. Zollinger RM, Ellison EC, O'Dorisio TM: Thirty years of experience with gastrinoma. World J Surg 8:427–432, 1984

    Google Scholar 

  12. Zollinger RM: Gastrinoma: Factors influencing prognosis. Surgery 97:49–54, 1985

    Google Scholar 

  13. Norton JA, Sugerbaker PH, Doppman JL, Wesley RA, Maton PN, Gardner JD, Jensen RT: Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg 203:352–359, 1986

    Google Scholar 

  14. Von Schrenck T, Howard JM, Doppman JL, Norton JA, Smith F, Maton PN, Vinayek R, Frucht H, Wank SA, Gardner JD, Jensen RT: Prospective study of chemotherapy in patients with metastatic gastrinoma. Gastroenterology 94:1326–1334, 1988

    Google Scholar 

  15. Waxman I, Gardner JD, Jensen RT, Maton PN: Peptic ulcer perforation as the presentation of the Zollinger-Ellison syndrome. Dig Dis Sci 16:19–24, 1991

    Google Scholar 

  16. Saeed ZA, Norton JA, Frank W, Young MD, Maton PN, Gardner JD, Jensen RT: Parenteral antisecretory drug therapy in patients with Zollinger-Ellison syndrome. Gastroenterology 96:1393–1402, 1989

    Google Scholar 

  17. Fraker DL, Norton JA, Saeed ZA, Maton PN, Gardner JD, Jensen RT: A prospective study of perioperative and postoperative control of acid hypersecretion in patients with Zollinger-Ellison syndrome undergoing gastrinoma resection. Surgery 104:1054–1063, 1988

    Google Scholar 

  18. Vinayek R, Frucht H, London JF, Miller LS, Stark HA, Norton JA, Cederberg C, Jensen RT, Gardner JD, Maton PN: Intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery. Gastroenterology 99:1016, 1990

    Google Scholar 

  19. Frucht H, Howard JM, Slaff JI, Wank SA, McCarthy DM, Maton PN, Vinayek R, Gardner JD, Jensen RT: Secretin and calcium provocative tests in Zollinger-Ellison syndrome. Ann Intern Med 111:713–722, 1989

    Google Scholar 

  20. Deveney CW, Deveney KS, Jaffe BM, Janes RS, Way LW: Use of calcium and secretin in the diagnosis of gastrinoma (Zollinger-Ellison syndrome). Ann Intern Med 87:680–686, 1977

    Google Scholar 

  21. Wank SA, Doppman JL, Miller DL, Collen MJ, Maton PN, Vinayek R, Slaff JI, Norton JA, Gardner JD, Jensen RT: Prospective study of the ability of computerized axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome. Gastroenterology 92:913–918, 1987

    Google Scholar 

  22. Maton PN, Miller DL, Doppman JL, Collen JM, Norton JA, Vinayek R, Slaff JI, Norton JA, Gardner JD, Jensen RT: Role of selective angiography in the management of patients with Zollinger-Ellison syndrome. Gastroenterology 92:913–918, 1987

    Google Scholar 

  23. London JF, Shawker TH, Doppman JL, Frucht H, Vinayek R, Stark HA, Miller LS, Miller DL, Norton JA, Jensen RT, Gardner JD, Maton PN: Prospective study of abnormal ultrasound in patients with Zollinger-Ellison syndrome. Radiology 178:763–767, 1991

    Google Scholar 

  24. McCarthy DM, Olinger EJ, May RJ, Long BM, Gardner JD: H2-histamine receptor blocking agents in the Zollinger-Ellison syndrome. Ann Intern Med 87:668–675, 1977

    Google Scholar 

  25. Collen MJ, Howard JM, McArthur KE, Rautman J-P, Cornelius MJ, Ciarleglio CA, Gardner JD, Jensen RT: Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion. Ann Intern Med 100:52–58, 1984

    Google Scholar 

  26. Jensen RT, Collen MJ, McArthur KE, Harvard JM, Maton PN, Cherner JA, Gardner JD: Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states. Am J Med 77(suppl B):90–105, 1984

    Google Scholar 

  27. Howard JM, Chremos AN, Collen MJ, McArthur KE, Cherner JA, Maton PN, Ciarleglio CA, Gardner JD, Jensen RT: Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: Comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome. Gastroenterology 88:1026–1033, 1985

    Google Scholar 

  28. Vinayek R, Howard JM, Maton PN, Wank SA, Slaff JI, Gardner JD, Jensen RT: Famotidine in the therapy of gastric hypersecretory states. Am J Med 81(suppl 4B):49–59, 1986

    Google Scholar 

  29. McArthur KE, Collen MJ, Maton PN, Cornelius MJ, Gardner JD, Jensen RT: Omeprazole: Effective convenient therapy for Zollinger-Ellison syndrome. Gastroenterology 88:939–944, 1985

    Google Scholar 

  30. Raufman J-P, Collins SM, Pandol SJ, Korman LY, Collen J, Cornelius MJ, Feld MK, McCarthy DM, Gardner JD, Jensen RT: Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome. Gastroenterology 84:108–113, 1983

    Google Scholar 

  31. McCarthy DM: Report on the United States experience with cimetidine in Zollinger-Ellison syndrome and other hypersecretory states. Gastroenterology 74:453–458, 1978

    Google Scholar 

  32. Jensen RT: Basis for failure of cimetidine in patients with Zollinger-Ellison syndrome. Dig Dis Sci 29:363–366, 1984

    Google Scholar 

  33. Clissold SP, Campoli-Richards DM: Omeprazole. Drugs 32:15–47, 1986

    Google Scholar 

  34. Regardh C-G: Pharmacokinetics and metabolism of omeprazole in man. Scand J Gastroenterol 21(suppl 118):99–104, 1986

    Google Scholar 

  35. Ostro MJ, Russel JA, Soldin SJ, Mahon WA, Jeejeebhoy KN: Control of gastric pH with cimetidine: Boluses versus primed infusions. Gastroenterology 89:532–537, 1985

    Google Scholar 

  36. Miller LS, Vinayek R, Frucht H, Gardner JD, Jensen RT, Maton PN: Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology 98:341–346, 1990

    Google Scholar 

  37. Maton PN, Frucht H, Vinayek R, Wank SA, Gardner JD, Jensen RT: Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery. Gastroenterology 94:294–299, 1988

    Google Scholar 

  38. Brogden RN, Heel RC, Speight TM, Avery GS: Cimetidine: A review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs 15:93–131, 1978

    Google Scholar 

  39. Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS: Ranitidine: A review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 24:267–303, 1982

    Google Scholar 

  40. Kimelblatt BJ, Cerra FB, Calleri G, Berg MJ, McMillen MA, Schentag JJ: Dose and serum concentration relationships in cimetidine-associated mental confusion. Gastroenterology 78:791–795, 1980

    Google Scholar 

  41. Epstein CM: Histamine H2 antagonists and the nervous system. Am Fam Physician 32:109–112, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bldg. 10, Room 9C-103, 20892, Bethesda, Maryland

    Rakesh Vinayek MD, William F. Hahne MD, Arthur R. Euler MD, Jeffrey A. Norton MD &  Robert T. Jensen MD

  2. Division of Gastroenterology, University of Maryland, Baltimore, Maryland

    Rakesh Vinayek MD, William F. Hahne MD, Arthur R. Euler MD, Jeffrey A. Norton MD &  Robert T. Jensen MD

  3. Glaxo Inc., Research Triangle Park, North Carolina

    Rakesh Vinayek MD, William F. Hahne MD, Arthur R. Euler MD, Jeffrey A. Norton MD &  Robert T. Jensen MD

Authors
  1. Rakesh Vinayek MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William F. Hahne MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arthur R. Euler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jeffrey A. Norton MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert T. Jensen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vinayek, R., Hahne, W.F., Euler, A.R. et al. Parenteral control of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Digest Dis Sci 38, 1857–1865 (1993). https://doi.org/10.1007/BF01296110

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01296110

Key Words

Search

Navigation